How big is the Plasmid Manufacturing Market | Size, Share & Growth Analysis 2026

How big is the plasmid manufacturing market?

The market growth is driven by the rising demand for plasmid DNA in gene therapy, cell therapy, and DNA-based vaccines, coupled with expanding outsourcing to CDMOs and rapid adoption of advanced biomanufacturing technologies.

Key Growth Drivers of the Plasmid Manufacturing Market

• Subsequent increase in demand of plasmid DNA in the fields of gene and cell therapy
• Rising use of DNA vaccines for infectious and chronic diseases
• Scaling up outsourcing to CDMOs in large plasmid production GMP grade
• Innovation in upstream and downstream manufacturing innovations
• Grants to biotechnology and biopharmaceutical research and development

Plasmid Manufacturing Market Trends

The plasmid manufacturing market is experiencing trends such as large-scale GMP-compliant production facilities, strategic partnerships between biotech firms and CDMOs, and a surge in demand for high-quality plasmids in CRISPR and synthetic biology research. Firms are investing in automation, disposable bioreactors and high-tech systems of purification to achieve greater scalability and efficiency. Long term demand is also being fuelled by the increased active clinical trials of DNA-based therapeutics.

Emerging Developments in the Plasmid Manufacturing Market

The plasmid manufacturing market is undergoing developments like capacity expansions by leading CDMOs, investments in high-throughput technologies, and the launch of specialized plasmid production services. The companies put an emphasis on a shortened time in production, rigorous regulatory obligations, elevated adaptability of supply chains worldwide. The rising partnerships to conduct commercial-scale manufacturing with pharma and biotech companies are changing the marketplace.

List of Leading Companies in the Plasmid Manufacturing Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. Aldevron (a Danaher Company)

Aldevron is a global leader in plasmid DNA manufacturing, providing cGMP plasmids, proteins, and mRNA to support gene therapy, vaccines, and cell therapy programs.

2. VGXI, Inc.

VGXI specializes in high-quality GMP plasmid DNA production, supporting DNA vaccines, gene therapy, and genetic medicine from preclinical through commercial stages.

3. Kaneka Eurogentec S.A. (Kaneka Corporation)

Eurogentec provides large-scale GMP plasmid DNA and biologics manufacturing, offering end-to-end solutions for vaccines, gene therapy, and cell therapies.

4. Lonza Group AG

Lonza delivers integrated CDMO services, producing plasmid DNA for gene therapy, vaccines, and regenerative medicine applications.

5. Thermo Fisher Scientific Inc.

Thermo Fisher supports plasmid manufacturing with advanced tools, kits, and CDMO services, serving molecular biology, clinical development, and cell therapies.

6. Wuxi Advanced Therapies (Wuxi AppTec)

Wuxi Advanced Therapies provides plasmid DNA, viral vector, and cell therapy manufacturing, enabling scalable GMP production for global biopharma.

7. Charles River Laboratories International, Inc.

Charles River offers plasmid DNA production, QC, and analytical testing services, accelerating gene therapy and vaccine development pipelines.

8. GenScript Biotech Corporation

GenScript provides custom plasmid DNA synthesis, cloning, and GMP manufacturing, serving research, vaccines, and therapeutic gene editing applications.

9. Touchlight Genetics Ltd.

Touchlight develops enzymatic DNA (doggy bone DNA) and plasmid DNA technologies, advancing gene therapy, genetic vaccines, and DNA-based medicines.

10. Catalent, Inc.

Catalent provides plasmid DNA development and GMP manufacturing, supporting next-gen biologics, gene-based therapies, and cell therapy programs.

How big is the Plasmid Manufacturing Market : FAQ's